Clinical trial
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukemia After Stopping TKI
NCT01596114 is registered in ClinicalTrials.gov with European LeukemiaNet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukemia After Stopping TKI
- Lead sponsor
- European LeukemiaNet
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 30, 2012
- Completion date
- December 31, 2019
- Enrollment
- 868 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myeloid leukemia